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Abstract 
Eicosapentaenoic acid is converted by cycle-oxygenase to 
the prostacyclin, PG13. Consequently eicosapentaenoic acid 
might protect the brain from the impairment in cerebral blood 
flow that follows temporary cerebral arterial occlusion. We 
studied the effect of 90% pure eicosapentaenoic acid, given 
intravenously, on cerebral blood flow, brain water and 
prostaglandins after ischemia in gerbils. Ischemia was 
produced by bilateral carotid occlusion for 15 min followed by 
reperfusion for 2 h. In experimental gerbils, 0.833 mg or 
0.167 mg of eicosapentaenoic acid (Na salt) was given 
intravenously followed by a continuous infusion of 1 mg h-l. 
Control gerbils were given 0.167 mg of linoleic acid (Na salt 
intravenously followed by a continuous infusion of 1 mg h' 1 
or a saline infusion. Regional cerebral blood flow was 
measured by the hydrogen clearance method and brain water by 
the specific gravity technique. Brain diene prostaglandins 
were measured by radioimmunoassay. In control gerbils cerebral 
blood flow decreased significantly during reperfusion and 
remained depressed after 2 h of reperfusion. In eicosapen- 
taenoic acid treated gerbils blood flow decreased initially but 
after 2 h of reperfusion blood flow was significantly higher 
than in control gerbils. Brain edema and brain diene 
prostaglandins were not significantly different between control 
and experimental groups. 
Our study indicates that eicosapentaenoic acid, given 
intravenously, improves cerebral blood flow after ischemia and 
reperfusion. We speculate that this effect may be due to the 
formation of the prostacyclin, PGI3. 
lMenta1 Health,.Research Institute and Department of 
Biological Chemistry, University of Michigan, Ann Arbor, 
Michigan 48109. 
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Introduction 
A therapeutic potential for eicosapentaenoic acid (EPA) 
was suggested by the findings of Dyerberg (1) who noted the 
high content of EPA in the maritime diet of Greenland Eskimos. 
EPA was suggested as an important factor in the low incidence 
of myocardial infarction in Eskimos (l-3). Dyerberg indicated 
that EPA could have an antiaggregatory action on blood 
platelets due to competitive inhibition of TXA2 synthesis. 
This is in accord with the observation that EPA is bound to the 
enzyme cycle-oxygenase from sheep vesicular gland with 
affinities (1.7 to 15 vM) equal to or greater than the Km value 
for arachidonate. EPA was thus suggested to be an effective 
competitive inhibitor (4). Moncada and Vane (5), however, 
regarded the protective effect as being due to the ability of 
the vessel wall to utilize EPA to make a Al7 prostacyclin 
(PGI3), a vasodilator and inhibitor of platelet aggregation, 
and an accompanying thromboxane A3, which is not active. In 
support of this concept, Dyerberg (6) recently reported that 
human umbilical blood vessel walls transform EPA to PG13. 
We previously reported that dietary supplements of 
menhaden oil, which is 17% EPA by weight, prevented impaired 
cerebral blood flow (CBF) and edema in ischemic gerbils (7). 
In this study the effect of 90% pure EPA, given intravenously, 
on CBF, edema and brain diene prostaglandins after ischemia and 
reperfusion is reported. 
Materials and Methods 
1) Surgical Procedure 
Male mongolian gerbils (Meriones unguiculatus) weighing 
50 to 77 g were anesthetized with ketamine (75 mg 
xylazine (20 mg kg-l) injected intraperitoneally. 
kg-l) and 
Anesthesia 
was maintained with ketamine 37.5 mg kg-l and xylazine 10 mg 
kg-l (i.p.) every 20 to 40 min as required for the duration 
of the experiment. A midline neck incision was made and the 
trachea was cannulated with a PE-90 polyethylene catheter. 
PE-10 polyethylene catheters were inserted into the left 
femoral artery and vein. The arterial catheter was connected 
to a blood pressure transducer and systemic arterial blood 
pressure was continuously monitored. The venous catheter was 
connected to a 1 cc glass syringe attached to a constant 
infusion pump. Arterial blood samples were obtained for blood 
gas analysis immediately after the last CBF measurement. Blood 
samples were not obtained prior to the last CBF to avoid the 
effects of phlebotomy on CBF and edema in ischemic gerbils 
(8). The right and left common carotid arteries were exposed 
in the neck with the aid of magnification. Both carotid 
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arteries were occluded with Mayfield clips for 15 min. The 
clips were then removed to restore cerebral circulation. In 
sham operated animals the carotid arteries were exposed but not 
occluded. In animals that had CBF measurements burr holes were 
made bilaterally over the frontal and parietal cortex. Four 
Teflon coated platinum electrodes (125 pm diameter) were 
inserted stereotactically 0.5 mm into the cerebral cortex. 
Exposed cortex around the electrodes was covered with moist 
Gelfoam and the electrodes were fixed in place with acrylic 
cement. A silver/silver chloride reference electrode was 
placed subcutaneously in the right leg. 
2) Measurements 
Regional CBF was measured by the hydrogen clearance 
technique (9). Brain specific gravity measurements were made 
using a bromobenzene-kerosene density gradient column as 
previously described (7). 
In gerbils that were used for prostaglandin 
determinations the brain was removed in less than 1 min and the 
left cerebral hemisphere was placed in pentane, cooled in dry 
ice. The frozen brains were weighed and placed in a 30 ml 
tissue grinding tube kept on ice. Aspirin-formic acid solution 
(1 ml) was added to the frozen tissue. Aspirin-formic acid 
solution was prepared by dissolving 0.207 g acetylsalicylic 
acid in 100 ml of 0.75% saline. Aliquots (4.5 ml) were frozen 
in plastic vials and stored. Prior to use, 0.5 ml of 88% 
formic acid was added to a vial containing the frozen aspirin 
solution and the contents were allowed to thaw slowly on ice. 
The tissue was slowly homogenized using a serrated-tip Teflon 
pestle. The homogenized tissue was poured into a test tube. 
The glass grinding tube was rinsed with 4 ml of ethyl acetate 
which was then added to the homogenized brain tissue in the 
test tube. The homogenized tissue and ethyl acetate were mixed 
for 30 set with a vortexer and centrifuged for 5 min at 2500 
rpm. The top layer was removed and dried under an airstream. 
Three milliliters of 0.1 M phostate buffered saline was added 
to the sample followed by 3 ml of petroleum ether (30-600C). 
The sample was mixed for 60 set 
d 
nd centrifuged as before. The 




6-keto-PGFla and thromboxane 
were radioimmunoassay using 3H-labellid 
compounds from New England Nuclear Corp. (10-12). The 
antibodies were from Upjohn except for 6-keto-PGFla , which 
was determined with kit (New England Nuclear). 
Dextran-coated charcoal wai used to separate bound from free 
ligand. The limits of sensitivity were 2 pg/tube (PGE2), 1.3 
pg/tube (PGF2a ), 4.5 pg/tube (6-keto- PGFlo ), and 0.7 
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pg/tube (TXB2). The cross-reactivity of the antibodies to 
the triene prostaglandins 
has not been determined: 
TXB3 and A17 6-keto PGFla 
Cross-reactivity of the antibody fob 
PGE2 to PGE3 was 7.8%. The cross-reactivity of the 
antibodies to other related prostaglandins were low. The 
percent of extraction recovery of prostanoids were 98.4% for 
PGE2, 99.1% for PGF~cY 96.8% for TXB2 and 96.7% for 
6-keto PGFlo . The backg;ound values for the mean extracted 
H20 blank and PBS buffer respecitvely were 12 and 36 pg/ml 
for PGE2, 16 and 16 pg/ml for PGF2o and 8 and 7 pg/ml for 
TXB2. Background values were 0 for 6-keto PGFlcr . The 
inter and intra-assay percent coefficient of variation, 
respectively, were 10.5 and 5.8 for PGE2, 8.7 and 2.0 for 
PGF2o , 4.9 an 4.3 for 6-keto PGFlo and 12.9 and 3.8 for 
TXB2. 
3) Preparation of Fatty Acids for Injection 
The EPA (all cis-5,8,11,14,17-eicosapentaenoic acid, 90% 
pure) was obtained as the ethyl ester from Nippon Kagakushiryo 
Co, Hokkaido, Japan. The contaminants inluded: 1.1% 18:4 
(n-3), 1.2% 20:4 (n-6), 0.7% 20:4 (n-3) and 1.9% 22:6 (n-3) 
The ester was saponified under nitrogen, using the valve 
of Raymond Firestone (Aldrich Chemical Co.) to remove air. 
About 250 mg were refluxed for 1 h in a l-piece condenser flask 
with 7 ml of 0.3 M NaOH in methanol-water (13). The reaction 
mixture was extracted with 5 ml of hexane, which removed about 
2 mg of oil, then acidified with HCl and extracted with three 
5-ml portions of hexane. The pooled extracts were washed with 
water, dried with sodium sulfate, and evaporated to dryness 
with a stream of nitrogen in a Thunberg tube. To the acid was 
added enough 0.3 M NaOH to bring the pH to about 8.3 and enough 
isotonic saline to bring the concentration of the acid to 10 mg 
ml-l. The air in the tube was removed with the Firestone 
valve and the mixture #was warmed and sonicated .,to produce a 
cloudy suspension. 
Portions of the suspension (0.4 ml) were dispensed into 
test tubes made from 0.6 mm O.D. Pyrex tubing. These were 
frozen in dry ice, evacuated with a high-vacuum pump, and 
sealed. The tubes were stored at -200C until use, when they 
were opened and diluted with an equal volume of alkaline saline 
(10 ml saline + 0.2 ml of 0.3 M NaOH) to yield a clear 
solution, pH about 8.5. 
For comparison, similar suspensions were prepared f.rom 
linoleic acid (cis,cis-9,12-octadecadienoic acid from Applied 
Science), with omisson of the saponification step. The sealed 
tubes were color coded (two colors, for each acid) for blind 
testing. 
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4) Experimental Protocol 
In all ischemic animals both carotid arteries were 
occluded for 15 min. In 30 gerbils that had CBF and brain 
water determinations, after 15 min of occlusion the clips were 
removed ,and cerebral circulation restored for 2 h. CBF 
measurements were taken prior to occlusion, during occlusion 
and 5 min, 30 min, 60 min and 120 min after reperfusion. The 
brains were then immediately removed for specific gravity 
determinations. 
In 20 gerbils, 0.0334 ml min-1 of 0.9% saline or EPA 
(0.835 mg) in saline was infused starting 5 min prior to 
carotid occlusion. The infusion was continued during occlusion 
and reperfusion at 0.2 ml h-l ( 1.0 mg h-l ) for 135 min. 
In a second experiment 0.167 mg of linoleic acid (n=5) or 0.167 
mg of EPA (n=5) was infused over 1 min starting immediately 
after carotid occlusion and was continued at a rate of 1 mg 
h-l for 135 min. 
Brain prostaglandins were determined in 40 gerbils. In 
sham operated EPA gerbils 0.167 mg min-l of EPA (n=lO) was 
infused for 5 min followed by a constant infusion of 1 mg 
h-1. After 65 min of infusion the brains were removed and 
assa ed 
min' r 
for prostaglandins. In ischemic EPA gerbils 0.167 mg 
of EPA (n=lO) was infused for 5 min followed by an 
infusion of 1 mg h-1 for 30 min. After 30 min of infusion 
both carotids were occluded for 15 min followed by 15 min of 
reperfusion. The infusion of EPA (1 mg h-1) continued during 
occlusion and reperfusion. Control gerbils (n=20) were given 
no infusions. In control ischemic gerbils ischemia was 
produced for 15 min followed by 15 min of reperfusion. After 
15 min of reperfusion in both control and EPA gerbils the 
brains were removed for prostaglandin analysis. 
5) Statistical Analysis 
An analysis of variance was performed between groups to 
determine significant differences between CBF, edema and 
prostaglandin levels. 
Results 
Prior to carotid occlusion, in saline control gerbils, 
regional CBF was 27.4 ml 100 g-1 min-1. During bilateral 
carotid occlusion, CBF was less than 5 ml 100 g-l min-1. 
There was a short period of hyperemia 5 min after reperfusion. 
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After 30 min of reperfusion CBF fell to 17.7 ml 100 
g-lm("‘1 and remained depressed at 19.2 ml 100 g-1 
min after 2 h of reperfusion. In gerbils infused with 
0.835 mg of EPA 5 min prior to ischemia followed by constant 
infusion during ischemia, CBF decreased from 27.4 ml 100 g-l 
min-1 to 19.6 ml 100 g-1 min-1 initially but after 2 h of 
reperfusion CBF was improved to 26.2 ml 100 g-1 min-1, 
significantly higher than control saline gerbils at p < 0.05 
(Fig. 1). In gerbils infused with 0.167 mg of EPA after 
ischemia, followed by constant infusion, CBF decreased from 
30.0 to 17.8 but improved after 2 h of reperfusion to 23.7 ml 
100 g-1 min-1. Animals infused with linoleic acid had 
blood flows similar to saline infused gerbils (Fig. 1). 
Brain edema was less in gerbils infused with EPA or 
linoleic acid compared with gerbils infused with saline (Fig. 
2). The differences between the 4 groups Here not significant 
at the 0.05 level. 
Brain levels of and 6-keto 
PGFla were higher 
PGE2, PGF2a TXB2 
after ischemia in ierbils infused with 
EPA. The differences were not significant, however (Table 1). 
Blood pressure and arterial blood gases remained within 
physiologic limits and were similar in all groups. There was 
no decrease in systemic blood pressure after EPA infusion . 
Discussion 
There is growing evidence that a variety of oxidized , 
products of arachidonate (thromboxane A2, prostacyclin 12, 
leukotrienes) are important in ameliorating or potentiating 
ischemic injury. During severe ischemia there is a 20 to 40 
fold increase in the tissue content of free arachidonate 
(14,15). Nhen blood flow is re-established, restoring tissue 
oxygen, arachidonic acid is converted to prostaglandins, 
prostacyclin and thromboxane (16,17). EPA is structurally 
similar to arachidonate and it may prevent platelet TXA2 
production by competitive inhibition of arachidopate oxidation 
by cycle-oxygenase (18). EPA ' itself "oxidized by 
cycle-oxygenase to a d7 prostacjzlin, PGI3 (5,6), which 
is an inhibitor of platelet aggregation, and to TXA3, which 
itself is inactive. TXA3 may have a beneficial effect, 
however, by competing with TXA2 for receptor sites. 
Intravenous infusion of EPA significantly improved 
post-ischemic CBF after 90 min of infusion. Although we did 
not measure A7 6-keto PGFla we speculate that improved 
post-ischemic CBF may be due 'to the formation of PG13. 
Further, intravenous infusion of ‘EPA may': theoretically, result 
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in a selective increase in PG13 in ischemic tissue. Gulp 
(19) reported that EPA is a poor substrate for cycle-oxygenase 
at peroxide levels which occur in non-ischemic tissue. 
Increasing peroxide tone in an incubate containing cyclo- 
oxygenase increased the conversion of EPA considerably. 
Accordingly, in areas of ischemia where peroxide levels are 
higher, the formation of PGI3 may be increased. Moncada 
(5,20) has also emphasized the importance of interactions 
between platelets and the vessel wall. It was suggested that 
platelets adhering to the vessel wall could possibly feed the 
vessel enzyme, prostacyclin synthetase, with endoperoxides, 
thereby enabling the vessel to produce more prostacyclin. In 
the ischemic area, platelets adhering to cerebral vessels could 
convert the EPA to cyclic endoperoxides and transfer these 
endoperoxides to the vessel wall where PG13 is formed. In 
non-ischemic tissue, without platelet adhesion to the vessel 
wall and with lower peroxide levels, the formation of PG13 
may be less. The absence of systemic hypotension after 
infusion of a large dose of EPA adds support to the suggestion 
that PG13 may be selectively formed in ischemic tissue. 
Brain diene prostaglandin and thromboxane levels were 
higher, but not significantly, in animals infused with EPA. 
These findings are difficult to interpret for several reasons. 
First, EPA is converted by cycle-oxygenase to triene 
prostaglandins, whereas arachidonate is the precursor of the 
diene prostaglandins. The cross-reactivity in our assay for 
PGE2 with PGE3 is relatively high, 7.8%. We have not 
determined the cross-reactivity for TX63 or Al7 6-keto 
PGFla . Therefore, a large production of PG13 or TXA3 may 
only be reflected as a slight increase in 6-keto PGFla or 
TXB2 due to cross-reactivity in our assay. Conversely, 
inhibition of diene prostaglandin production by EPA may be 
masked by increased triene prostaglandins. Second, there is 
evidence (unpublished data in our laboratory) that the brain 
thromboxane measured by our assay does not entirely reflect the 
level of platelet tlIrOinbOXane. There is recent evidence that 
the vessel wall itself is also a source of thromboxane (21). 
The formation of thromboxane from this source is relatively 
insensitive to aspirin (22) and, perhaps, to EPA. Third, our 
infused EPA contained a small amount of arachidonate which may 
have been converted into diene prostaglandins. 
In a previous report (7) we noted that dietary 
supplements of menhaden oil, which is 17% EPA by weight, 
prevented brain water accumulation during the post-iscnemic 
period. Intravenous infusion of EPA did not significantly 
reduce brain water accumulation. Prevention of brain edema by 
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EPA may require the incorporation of EPA into cell membranes, 
which can only be achieved by long term dietary supplements of 
EPA. The menhaden oil could also contain other polyunsaturated 
fatty acids which could have accounted for the reduced brain 
water accumulation. In this regard it is of interest that 
brain water accumulation was lowest, but not significantly, in 
gerbils infused with linoleic acid although CBF was not 
improved. 
In conclusion, intravenous infusion of EPA improved 
post-ischemic CBF. We speculate that the increased CBF may be 
due in part to the production of PGI3. Further investigation 
into the mechanism of this beneficial effect and its clinical 
applicability in ischemia is warranted. 
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